Real-world safety profile of opicapone: a comprehensive pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database.

This study provides a real-world analysis of opicapone, a peripheral, selective, and reversible COMT inhibitor approved as adjunctive therapy to levodopa/carbidopa for managing 'off' episodes in Parkinson's disease, utilizing the FDA Adverse Event Re…

Preview only. Read the full abstract at the source